Methotrexate for maintenance of remission in Crohn's disease

Cochrane Database of Systematic Reviews

Volumn , Issue 4, 2009, Pages

  Patel, Vishal ^a   MacDonald, John K ^b   McDonald, John W D ^b   Chande, Nilesh ^a  

^a LONDON HEALTH SCIENCES CENTRE   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Administration, oral; Crohn disease *drug therapy ; Drug administration schedule; Humans; Immunosuppressive agents *administration dosage; adverse effects ; Injections, intramuscular; Methotrexate *administration dosage; adverse effects ; Randomized controlled trials as topic; Remission induction

Indexed keywords

FOLIC ACID; MERCAPTOPURINE; METHOTREXATE; PLACEBO;

ABDOMINAL PAIN; ARTHRALGIA; CLINICAL TRIAL; COMMON COLD SYMPTOM; CROHN DISEASE; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; HEADACHE; HUMAN; NAUSEA; PROPHYLAXIS; RELAPSE; REMISSION; REVIEW; SYSTEMATIC REVIEW; TREATMENT OUTCOME; VOMITING;

EID: 77950156591     PISSN: 1469493X     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD006884.pub2     Document Type: Review

References (21)

1. Feagan 2000 {published data only} Feagan BG, Fedorak RN, Irvine EJ, Wild G, Sutherland L, Steinhart AH, et al.A comparison of methotrexate with placebo for the maintenance of remission in Crohn's disease. North American Crohn's Study Group Investigators. N Engl J Med 2000;342(22): 1627-32. [PUBMED: 10833208]
2. Maté-Jiménez 2000 {published data only} Maté-Jiménez J, Hermida C, Cantero-Perona J, Moreno-Otero R. 6-mercaptopurine or methotrexate added to prednisone induces and maintains remission in steroid-dependent inflammatory bowel disease. Eur J Gastroenterol Hepatol 2000;12(11):1227-33. [PUBMED: 11111780]
3. Oren 1997 {published data only} Oren R, Moshkowitz M, Odes S, Becker S, Keter D, Pomeranz I, et al.Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial. Am J Gastroenterol 1997;92: 2203-9. [PUBMED: 9399753]
4. Ardizzone 2003 {published data only} Ardizzone S, Bollani S, Manzionna G, Imbesi V, Colombo E, Bianchi Porro G. Comparison between methotrexate and azathioprine in the treatment of chronic active Crohn's disease: a randomised, investigator-blind study. Dig Liver Dis 2003;35(9): 619-27. [PUBMED: 14563183]
5. Arora 1999 {published data only} Arora S, Katkov W, Cooley J, Kemp JA, Johnston DE, Schapiro RH, et al.Methotrexate in Crohn's disease: results of a randomized, double-blind, placebo-controlled trial. Hepatogastroenterology 1999; 46(27):1724-9. [PUBMED: 10430331]
6. Egan 1999a {published data only} Egan LJ, Sandborn WJ, Tremaine WJ, Leighton JA, Mays DC, Pike MG, et al.A randomized dose-response and pharmacokinetic study of methotrexate for refractory inflammatory Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 1999;13(12): 1597-604. [PUBMED: 10594394]
7. Alfadhli 2004 Alfadhli AA, McDonald JW, Feagan BG. Methotrexate for induction of remission in refractory Crohn's disease. Cochrane Database of Systematic Reviews 2004, Issue 4. [Art. No.: CD003459. DOI: 10.1002/14651858.CD003459.pub2]
8. Arthur 2002 Arthur V, Jubb R, Homer D. A study of parenteral use of methotrexate in rheumatic conditions. J Clin Nurs 2002;11(2): 256-63. [PUBMED: 11903725]
9. Baert 2003 Baert F, Noman M, Vermeire S, Van Assche G, D' Haens G, Carbonez A, et al.Influence of immunogenicity on the long-term efficacy of infliximab in Crohn's disease. N Engl J Med 2003;348 (7):601-8. [PUBMED: 12584368]
10. Balis 1988 Balis FM,Mirro J Jr, Reaman GH, Evans WE,McCully C, Doherty KM, et al.Pharmacokinetics of subcutaneous methotrexate. J Clin Oncol 1988;6(12):1882-6. [PUBMED: 3199171]
11. Chebli 2007 Chebli JM, Gaburri PD, De Souza AF, Pinto AL, Chebli LA, Felga GE, et al.Long-term results with azathioprine therapy in patients with corticosteroid-dependent Crohn's disease: open-label prospective study. J Gastroenterol Hepatol 2007;22(2):268-74. [PUBMED: 17295882]
12. Egan 1999b Egan LJ, Sandborn WJ, Mays DC, Tremaine WJ, Fauq AH, Lipsky JJ. Systemic and intestinal pharmacokinetics of methotrexate in patients with inflammatory bowel disease. Clin Pharmacol Ther 1999;65(1): 29-39. [PUBMED: 9951428]
13. Feagan 1995 Feagan BG, Rochon J, Fedorak RN, Irvine EJ, Wild G, Sutherland L, et al.Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 1995;332(5):292-7. [PUBMED: 7816064]
14. Hanauer 2002 Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, et al.Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002;359(9317):1541-9. [PUBMED: 12047962]
15. Higgins 2003 Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557- 60. [PUBMED: 12958120]
16. Higgins 2008 Higgins JPT, Altman DG (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.0 [updated February 2008]. The Cochrane Collaboration, 2008. Available from www.cochrane-handbook.org.
17. Jadad 1996 Jadad AR, Moore RA, Carroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al.Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Control Clin Trials 1996;17 (1):1-12. [PUBMED: 8721797]
18. Lichtenstein 2006 Lichtenstein GR, Abreu MT, Cohen R, Tremaine W, American Gastroenterological Association. American Gastroenterological Association Institute medical position statement on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease. Gastroenterology 2006;130(3):935-9. [PUBMED: 16530531]
19. Prefontaine 2009 Prefontaine E, Sutherland LR, MacDonald JK, Cepoiu M. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2009, Issue 1. [Art. No.: CD000067. DOI: 10.1002/14651858.CD000067]
20. Rampton 2001 Rampton DS. Methotrexate in Crohn's disease. Gut 2001;48(6): 790-1. [PUBMED: 11358896]
21. Steinhart 2003 Steinhart AH, Ewe K, Griffiths AM, Modigliani R, Thomsen OO. Corticosteroids for maintenance of remission in Crohn's disease. Cochrane Database of Systematic Reviews 2003, Issue 4. [Art. No.: CD000301. DOI: 10.1002/14651858.CD000301]